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BRIEF COMMUNICATION
SEROEPIDEMIOLOGICAL ASPECTS OF HUMAN Strongyloides stercoralis INFECTIONS IN CHILE
Rubén MERCADO(1,2), Maria Isabel JERCIC(3), Sergio ALCAYAGA(4), Fabiana M. de PAULA(5), Marlene T. UETA(5) & Julia M. COSTA-CRUZ(6)
SUMMARY
To determine the frequency of Strongyloides stercoralis antibodies by means of the enzyme linked immunosorbent assay
(ELISA) in Chile, in 2001-2003, 675 blood samples of patients of two psychiatric hospitals and 172 of healthy individuals (doctors,
nurses and paramedicals) of these institutions, and 1,200 serum samples of blood donors of Northern region (Arica and Antofagasta),
Central region (Valparaiso and Santiago) and Southern region (La Union) were collected. ELISA showed positivity of 12.1% in
psychiatric hospitalized patients, none (0%) in the health personnel and 0.25% in blood donors (p < 0.05). Only in blood donors of
Arica (1%) and La Union (0.5%) the ELISA test was positive suggesting that strongyloidiasis is focalized in determinate zones of
the country. In Chile, human infections by S. stercoralis are endemic with very low frequency in apparently healthy individuals
and high prevalence in risk groups such as the mentally ill hospitalized patients.
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Human infection by the nematode Strongyloides stercoralis is
especially endemic throughout tropical and warm temperate regions
of the world3,11. In other geographical zones or in industrialized
countries, strongyloidiasis still represent a clinical-epidemiological
problem focalized in institutions for the mentally ill patients10. Scarce
epidemiological information about strongyloidiasis in Latin-American
countries is available. Epidemiological studies in selected studied
populations of Brazil, Peru, Colombia and Venezuela showed frequency
of 13.0%14, 8.7%20, 2.3%8 and 1.4%7 respectively. In Chile, in 1983, a
mortal case of disseminated strongyloidiasis in a hospitalized
psychiatric 53 year-old man was reported17. Enteroparasitic infections
surveys carried out in psychiatric hospitalized patients of the V
geopolitical region of Chile in 1985 and 1990 showed percentages of
S. stercoralis infections of 11.6 (57/490)5 and 7.0 (16/229)9 respectively.
In 2000, in a psychiatric hospital of Santiago, Chile it was observed
that 20 patients presented elevated blood eosinophiles count.
Coproparasitological examination of seven stool samples of each patient
permits the detection of larvae of S. stercoralis in four of them15.
The laboratory diagnosis of strongyloidiasis by using commonly
stool examination methods such as formol-ethyl acetate techniques -
routinely used in Chile - is considered of low sensitivity, so the
identification of S. stercoralis infected individuals is difficult4.
Immunodiagnosis of S. stercoralis infection has been attempted with
several serological tests. Enzyme linked immunosorbent assay (ELISA)
permits the detection of serum specific IgG1 , and can be used as an
epidemiological tool to determine the prevalence of strongyloidiasis
in a given region or population18,19,20. In Chile, ELISA test to detect S.
stercoralis serum antibodies against an alkaline protein extract of the
filariform larvae of S. venezuelensis was standardized16.
The objective of this communication is to describe some
epidemiological aspects of the infections caused by S. stercoralis in
two psychiatric institutions of Chile, including the total population of
the interned patients and the health personnel of the referred institution.
Also, we determined the percentage of positive ELISA test in blood
donors of three different geographical regions of Chile: north, central
and south to compare it frequency with the observed in the hospitalized
psychiatric patients.
A total of 2047 serum samples were collected from Chile
individuals, during 2001-2003. In hospital 1 (from the V geopolitical
region of Chile) blood samples were taken from 343 patients. According
to sex 231 (67.3%) were men and 112 (32.7%) women. Ninety five
health personnel (physicians, nurses and paramedical individuals) were
studied. In hospital 2 (from Santiago, Metropolitan region) 332 bloods
samples were taken, 224 from men (67.5%) and 108 from women
(32.5%) psychiatric patients. Health personnel studied in this institution
were 77. Serum samples of blood donors were obtained from the
northern cities of Arica (n = 200) and from Antofagasta (n = 200),
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from the central region cities of Valparaiso (n = 100) and Santiago (n =
500) and from the semi-rural southern city of La Union (n = 200). All
biological samples were obtained under ethical protocol for
epidemiological studies approved by the health institutions involved.
ELISA was performed as we previously described16 using a
filariform larval alkaline extract of Strongyloides venezuelensis and a
cut-off value of 0.33 OD. Statistical significance of frequency values
observed was determined by using the program STATCALC of
EPIINFO 6.0. Results were considered significant at p < 0.05.
Figure 1 shows the seropositivity results for S. stercoralis antibodies
in hospitalyzed psychiatric patients and blood donors of the different
regions studied. In blood donors a positive ELISA was observed in
two serum samples in Arica city (1.0%) and in one in La Union city
(0.5%). Positive frequency observed in a total of 1,200 of these serum
samples was 0.25% and among 675 psychiatric patients was 12.1% (p
< 0.05). Table 1 shows the seroprevalence of S. stercoralis infections
according to sex and age detected by means of ELISA in psychiatric
patients from hospital 1 of the V geopolitical region and hospital 2 of
the Metropolitan region of Chile. A total of 40/343 patients interned in
the hospital 1 presented an ELISA positive test (11.7%). By sex, 7.1%
of the women studied and 13.9% of the men were positive. This
difference was statistically significant (p < 0.05). The most frequent
age group affected was those of 21 to 39 year-old in both sexes. Similar
results were observed in the hospital 2. A total of 42/332 (12.7%) of
the patients presented ELISA positive. By sex, 6.5% of women and
15.6% of men had specific antibodies. This difference was statistically
significant (p < 0.05). No positive ELISA test was observed in the
health personnel of both Hospitals.
In immunocompetent individuals most infections by S. stercoralis
are chronic, however, in some situations hyperinfection or disseminated
infection has been found usually associated with host
immunosuppression2,12,13 . CONWAY et al.4 considered that there is a
typically persistent infection by S. stercoralis over decades in a small
fraction of the population of endemic regions.
In Chile, our results of the seroepidemiology of S. stercoralis
infections in blood donors of different cities showed that the prevalence
of antibodies was 0.25%, suggesting that strongyloidiasis frequency is
very low and occurred in determinate geographic areas. Comparison of
prevalence percentages observed in hospitalized psychiatric patients (11.7
- 12.7%) and in blood donors (0.25%) indicates that the transmission of
S. stercoralis in Chile is facilitated in the closed environment of the
Table 1
Seroprevalence of Strongyloides stercoralis infections, according to sex and age, detected by means of ELISA in psychiatric patients from hospital 1 of the V
geopolitical region and hospital 2 of the Metropolitan region of Chile
Age groups Men Women Total
(years) No./positive (%) No./positive (%) No./positive (%)
Hospital 1 Hospital 2 Hospital 1 Hospital 2
21-29  20/5(25.0) 11/1(9.1) 7/1(14.3) 4/0(0.0)  42/7(16.7)
30-39  36/8(22.2) 53/8(15.1) 26/4(15.4) 21/0(0.0) 136/20(14.7)
40-49  54/7(13.0) 68/9(13.2) 31/3(9.7) 27/2(7.4) 180/21(11.7)
50-59  58/6(10.3) 45/7(15.6) 21/0 (0.0) 19/1(5.3) 143/14(9.8)
60-69  34/5(14.7) 24/4(16.7) 11/0(0.0) 21/3(14.3) 90/12(13.3)
70-79  25/1(4.0) 18/2(11.1) 12/0(0.0) 12/1(8.3) 67/4(6.0)
80-89  2/0(0.0) 4/3(75.0) 3/0(0.0) 3/0(0.0) 12/3(25.0)
> 90  2/0(0.0) 1/1(100) 1/0(0.0) 1/0(0.0)  5/1(20.0)
Total 231/32(13.9) 224/35(15.6) 112/8(7.1) 108/7(6.5) 675/82(12.1)
Fig. 1 - Map of Chile showing percentages of ELISA positive for Strongyloides stercoralis
antibodies in hospitalized psychiatryc patients (HPP) and blood donors (BD) of the different
regions studied.
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psychiatric institution. Geophagy and coprophagy frequently observed
among mentally affected or retarded patients probably play important
roles in the acquisition and spread of the infection. COSTA-CRUZ et
al.6 alerted that strongyloidiasis is not only associated with barefoot
walking of individuals but with handled soils with unprotected hands
and drinking unfiltered waters. Studies performed by CORNEJO et al.5
and GARIBALDI et al.9 by using formalin-ether techniques to detect
larvae of S. stercoralis in the same hospital showed frequencies of 11.6%
(57/490) and 7.0% (16/229) respectively. These prevalence rates were
similar to those determined in this study using ELISA. S. stercoralis
infections are difficult to control in closed institutions, maintaining high
frequencies along at least 20 years. In this study of hospitalized mentally
ill patients, we observed that ELISA test was a very useful tool to
determining the seroepidemiology of infections by S. stercoralis,
contributing to define the transmission patterns, which are valuable basic
information to apply control measures, such as chemotherapy and
improvement of sanitary conditions.
In Chile, human infections by S. stercoralis are endemic with very
low frequency in apparently healthy individuals and high prevalence
in risk groups such as the mentally ill hospitalized patients.
RESUMO
Aspectos soroepidemiológicos da infecção humana por
Strongyloides stercoralis no Chile
Entre os anos de 2001-2003 foram coletadas amostras de sangue
de 675 pacientes de dois hospitais psiquiátricos da região central do
Chile, 172 de indivíduos sadios (médicos, enfermeiros e paramédicos)
destas instituições e 1200 de doadores de sangue de cidades das regiões
norte (Arica e Antofagasta), central (Valparaiso e Santiago) e sul (La
Union) para determinar a frequência de anticorpos anti Strongyloides
stercoralis mediante a reação de enzyme linked immunosorbent assay
(ELISA). Foram observadas soropositividade de 12.1% em pacientes
de hospitais psiquiátricos e de 0,25% em doadores de sangue (p <
0.05). Todas as amostras dos indivíduos sadios foram não reagentes.
Entre os doadores de sangue a soropositividade ocorreu somente nos
indivíduos de Arica (1,0%) e La Union (0,5%) sugerindo que a
estrongiloidíase poderia estar localizada em determinadas áreas
geográficas do país. Conclui-se que no Chile as infecções por S.
stercoralis seriam endêmicas, de baixa freqüência e afetando
especialmente grupos de risco como os pacientes psiquiátricos.
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